TVARDI THERAPEUTICS INC (TVRD) Stock Balance Sheet
NASDAQ:TVRD • US1407553072
Current stock price
3.52 USD
-0.16 (-4.35%)
At close:
3.37 USD
-0.15 (-4.26%)
Pre-Market:
| MRQ (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 21.42M | 37.90M | 51.77M | 63.70M | 13.50M | |||
| Marketable Securities | 15.04M | 0.00 | 48.98M | 81.70M | 153.60M | |||
| Receivables | N/A | 4.50M | 4.02M | 4.50M | 1.20M | |||
| Inventories | N/A | 900.00K | 2.82M | 2.40M | 2.60M | |||
| Other Current Assets | 1.98M | 529.00K | 8.56M | 16.70M | 2.50M | |||
| Total Current Assets | 38.44M | 43.83M | 116.16M | 168.90M | 173.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 223.00K | 0.00 | 8.19M | 2.00M | 3.60M | |||
| Investments And Advances | N/A | N/A | 0.00 | 11.40M | 69.80M | |||
| Intangibles | 338.00K | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 17.00K | 0.00 | 1.50M | 0.00 | 400.00K | |||
| Total Non-Current Assets | 578.00K | 0.00 | 9.69M | 13.30M | 73.80M | |||
| TOTAL ASSETS | 39.02M | 43.83M | 125.84M | 182.20M | 247.10M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 6.96M | 2.54M | 14.01M | 13.90M | 12.00M | |||
| Accounts Payable | 4.08M | 1.43M | 11.58M | 9.60M | 5.60M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 11.04M | 3.97M | 25.59M | 23.50M | 17.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 44.45M | 37.08M | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 115.00K | 44.45M | 6.09M | 0.00 | 1.90M | |||
| Total Non-Current Liabilities | 115.00K | 44.45M | 43.17M | 0.00 | 1.90M | |||
| TOTAL LIABILITIES | 11.15M | 48.42M | 68.76M | 23.50M | 19.50M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -103.17M | -755.61M | -684.75M | -566.20M | -480.80M | |||
| Additional Paid In Capital | 131.03M | 751.01M | 742.04M | 726.60M | 708.60M | |||
| Common Shares | 9.00K | 5.00K | 54.00K | 100.00K | 100.00K | |||
| Other Shareholders' Equity | 7.00K | N/A | -260.00K | -1.70M | -400.00K | |||
| Shares Outstanding | 9.38M | 1.52M | 1.51M | 1.49M | 1.49M | |||
| Tangible Book Value per Share | 2.94 | -3.01 | 37.72 | 2.95 | 4.25 | |||
| Total Shareholders' Equity | 27.87M | -4.59M | 57.09M | 158.80M | 227.50M | |||
| TOTAL LIABILITIES AND EQUITY | 39.02M | 43.83M | 125.84M | 182.20M | 247.10M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | -9.68 | 0.65 | N/A | N/A | |||
| Current Ratio | 3.48 | 11.03 | 4.54 | 7.19 | 9.85 | |||
| Return On Assets (ROA) | -35.74% | -161.70% | -94.17% | -46.93% | -35.77% | |||
| Return On Equity (ROE) | -50.04% | N/A | -207.61% | -53.84% | -38.86% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | N/A | N/A | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21